Mode
Text Size
Log in / Sign up
N/A Completed N=165 Randomized Quadruple-blind Prevention

The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids

Source: ClinicalTrials.gov NCT00951912 ↗
Enrolled (actual)
165
Serious AEs
0.0%
Results posted
Oct 2012
Primary outcomePrimary: Percentage Change in Fasting Plasma Glucose — -1.80; -1.00; -4.89 percentage of change — p=<0.05

Summary

Many studies showed that soy foods or soy isoflavones can lower the risk of cardiovascular disease (CVD), osteoporosis and some cancers, but few human studies assessed effects of purified isoflavone components (genistein and daidzein) on glucose metabolism. This double-blinded, randomized, placebo-controlled trial will examine the effects of purified genistein and daidzein on glucose metabolism in prediabetic or diabetic women. One hundred and eighty eligible women age 30-70 years(without any treatment of diabetic drugs) will be recruited and randomly allocated into the following three arms: Placebo (10g isolated soy protein, ISP); Genistein (10g ISP + 50mg genistein); Daidzein (10g ISP + 50mg daidzein) per day for 6 mo. Fasting glucose, lipids, insulin, inflammation marks and post-load for glucose and insulin will be determined at 0, 3th, and 6th month. Changes in these indices will be compared among the three groups.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage Change in Fasting Plasma Glucose
-1.80; -1.00; -4.89 <0.05 sig
PRIMARY
Percentage Change in 120-minutes Postload Plasma Glucose
-4.90; -3.13; -5.59 <0.05 sig
PRIMARY
Percentage Change in HbA1C
-1.38; -1.37; -1.30 <0.05 sig
PRIMARY
Percentage Change in AUC of Glucose
-6.23; -3.27; -5.24 <0.05 sig
PRIMARY
Percentage Change in Fasting Plasma Insulin
25.27; 21.41; 6.06 <0.05 sig
PRIMARY
Percentage Change in HOMA-IR
22.83; 21.60; -0.22 <0.05 sig
PRIMARY
Percentage Change in QUICKI
2.32; 0.18; 6.29 <0.05 sig
PRIMARY
Percentage Change in Total Cholesterol
2.85; -0.59; -0.64 <0.05 sig
PRIMARY
Percentage Change in Triglyceride
5.93; 3.43; -1.56 <0.05 sig
PRIMARY
Percentage Change in High Density Lipoprotein Cholesterol
3.18; 1.36; 2.15 <0.05 sig
PRIMARY
Percentage Change in Low Density Lipoprotein Cholesterol
1.08; -0.93; 1.86 <0.05 sig
SECONDARY
Total Urinary Isoflavones
8.538; 25.818; 15.467 <0.05 sig
SECONDARY
Urinary Daidzein
3.34; 11.80; 3.73 <0.05 sig
SECONDARY
Urinary Genistein
1.32; 1.89; 6.54 <0.05 sig
SECONDARY
Total Energy Intake at Follow-up
1575; 1473; 1579 <0.05 sig

Eligibility Criteria

Inclusion Criteria

  • Chinese women aged 30-70 y
  • Fasting glucose >=5.6 mmol/l; post-load glucose >=7.8 mmol/l

Exclusion Criteria

  • Diabetes renal diseases
  • Confirmed CVD, chronic liver,kidney diseases,Thyroid disease
  • Medications affecting glucose or lipid metabolism
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00951912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search